Related references
Note: Only part of the references are listed.Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Tomáš Šimůnek et al.
Pharmacological Reports (2014)
Evaluation for Antioxidant and Renoprotective Activity of Olmesartan Using Nephrectomy Rats
Daisuke Kadowaki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method
Shuichiro Araki et al.
HYPERTENSION RESEARCH (2009)
8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis
ATHANASIOS VALAVANIDIS et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2009)
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity
Mohamed A. Ibrahim et al.
PHARMACOLOGICAL RESEARCH (2009)
Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting
Franco Testore et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
Filomena de Nigris et al.
EUROPEAN JOURNAL OF CANCER (2008)
Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity
Ioannis Germanakis et al.
PEDIATRIC BLOOD & CANCER (2008)
Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction
Fuzhong Qin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit
H. Aupperle et al.
VETERINARY PATHOLOGY (2007)
Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature
A. K. Chow et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls
J. Robert
CELL BIOLOGY AND TOXICOLOGY (2007)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity
Martin Sterba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats
Mayako Soga et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice
K Kizaki et al.
PHARMACOLOGICAL RESEARCH (2006)
Myocardial proteases and matrix remodeling in inflammatory heart disease
S Rutschow et al.
CARDIOVASCULAR RESEARCH (2006)
Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy
LH Li et al.
CIRCULATION (2006)
Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone
H Nakamae et al.
CANCER (2005)
Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK
N Gurusamy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer
L Elbl et al.
EUROPEAN JOURNAL OF PEDIATRICS (2003)
Interactions of angiotensin II with MAD(P)H oxidase, oxidant stress and cardiovascular disease
DG Harrison et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2003)
Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat
P Dziegiel et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2002)
Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy
K Watanabe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Role of oxidative stress in cardiovascular diseases
NS Dhalla et al.
JOURNAL OF HYPERTENSION (2000)
Share Paper
